Athalia R. Pyzer
- Co-authors
- David AviganJacalyn RosenblattLeandra ColeDina StroopinskyEleni AnastasiadouFrank J. SlackChristopher S. ChenStefania Uccini
- Topics
- SARS-CoV-2 and COVID-19 Research (5 papers)COVID-19 Clinical Research Studies (5 papers)Lymphoma Diagnosis and Treatment (4 papers)
- Cited by
- ImmunologyOncologyHematology
- Partner nations
- United StatesItalyGermany
In The Last Decade
Athalia R. Pyzer
20 papers receiving 394 citations
Peers
Comparison fields: 5 of 59
- Immunology 200
- Oncology 183
- Molecular Biology 156
- Cancer Research 63
- Hematology 57
Countries citing papers authored by Athalia R. Pyzer
This map shows the geographic impact of Athalia R. Pyzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athalia R. Pyzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athalia R. Pyzer more than expected).
Fields of papers citing papers by Athalia R. Pyzer
This network shows the impact of papers produced by Athalia R. Pyzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athalia R. Pyzer. The network helps show where Athalia R. Pyzer may publish in the future.
Co-authorship network of co-authors of Athalia R. Pyzer
This figure shows the co-authorship network connecting the top 25 collaborators of Athalia R. Pyzer. A scholar is included among the top collaborators of Athalia R. Pyzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athalia R. Pyzer. Athalia R. Pyzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 31 | |
| 3 | 0 | |
| 4 | 13 | |
| 5 | Treatment with tocilizumab does not inhibit induction of anti-COVID-19 antibodies in patients with severe SARS-CoV-2 infection | 0 |
| 6 | 1 | |
| 7 | 129 | |
| 8 | 1 | |
| 9 | 10 | |
| 10 | 23 | |
| 11 | 16 | |
| 12 | 2 | |
| 13 | 1 | |
| 14 | 2 | |
| 15 | 80 | |
| 16 | 28 | |
| 17 | 2 | |
| 18 | 1 | |
| 19 | 44 | |
| 20 | 1 |
About Athalia R. Pyzer
Athalia R. Pyzer is a scholar working on Immunology, Oncology and Infectious Diseases, having authored 23 papers that have together received 398 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Immunology (200 citations), Oncology (183 citations) and Hematology (57 citations). Athalia R. Pyzer has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include David Avigan, Jacalyn Rosenblatt, Leandra Cole, Dina Stroopinsky, Eleni Anastasiadou, Frank J. Slack, Christopher S. Chen, Stefania Uccini, Alan Jiao and Martina Severa. Their work appears in journals such as Blood, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.